COMPANIES PRODUCTS INVESTOR RELATIONS CAREER NEWS DE ENG IR News Page 1 of 2. 1 2 Next 11/19/2021 CHEPLAPHARM continues strong growth Greifswald, November 19, 2021 - CHEPLAPHARM increases sales in the first nine months of 2021 compared to the previous year by 63% to € 793 million and ... continue reading / pdf 10/13/2021 CHEPLAPHARM signs contracts Greifswald, October 13, 2021 This week, Cheplapharm and Sanofi agreed on an asset deal for 10 established products. That… continue reading / pdf June 16, 2021 CHEPLAPHARM invests in portfolio against infectious diseases Greifswald, June 16, 2021 - CHEPLAPHARM is investing in a portfolio for the treatment of various infectious diseases from Astellas. With the… continue reading / pdf 05/04/2021 CHEPLAPHARM continues on the road to success Greifswald - CHEPLAPHARM is consistently implementing its growth strategy in 2020 and increasing sales by over 30% to € 680 million. With the… continue reading / pdf 04/01/2021 Expansion of the management on April 1st CHEPLAPHARM is pleased to inform you about an expansion of its management.Effective April 1, 2021, Dr. Keyarasch ... continue reading / pdf 03/01/2021 Change in management CHEPLAPHARM is pleased to be able to inform you about the change in the management.With effect from March 1, 2021 Edeltraud will ... continue reading / pdf 02/03/2021 CHEPLAPHARM Arzneimittel GmbH announces that it has received the necessary approvals CHEPLAPHARM Arzneimittel GmbH CHEPLAPHARM Arzneimittel GmbH reports that it has received the necessary consents in connection with obtaining ... continue reading / pdf 01/26/2021 CHEPLAPHARM Arzneimittel GmbH announces appeal for approval CHEPLAPHARM Arzneimittel GmbHCHEPLAPHARM Arzneimittel GmbH terminates the call for consent with regard to their3.500% Senior Secured Notes due 2027 ... continue reading / pdf 11/01/2021 CHEPLAPHARM acquires the rights to Rivotril ® Greifswald, January 11th, 2021 - CHEPLAPHARM is expanding its portfolio by acquiring the marketing rights for Rivotril ® from Roche. "As a successful ... continue reading / pdf 05/01/2021 Largest acquisition so far for CHEPLAPHARM Greifswald, January 5th, 2021 - CHEPLAPHARM successfully completes the takeover of Takeda's cardiovascular and metabolic portfolio Measured at… continue reading / pdf Page 1 of 2. 1 2 Next 2020 2019 2018 Investor Relations IR News Financing strategy Ratings Financial reports ESG information Investors Domain IR contact IR newsletter IMPRINT DATA PROTECTION CONDITIONS CONTACT This site uses website tracking technologies from third parties in order to offer its services, to continuously improve them and to display advertisements in line with the interests of the users. I agree and can revoke or change my consent at any time with effect for the future. REFUSE ACCEPT MORE Powered by